Market News Video
MNV MNV 10 Bargains You Can Buy Cheaper Than Insiders Did
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Gilead Sciences Moves Up In Market Cap Rank, Passing Texas Instruments
Tuesday, February 6, 4:36 PM ET, by Market News Video Staff

In the latest look at the underlying components of the S&P 500 ordered by largest ...

Noteworthy ETF Inflows: IVW, ADBE, CHTR, GILD
Thursday, February 8, 11:12 AM ET, by Market News Video Staff

Symbols mentioned in this story: IVW, ADBE, CHTR, GILD Exchange traded funds (ETFs) trade just ...

Health Care Select Sector SPDR Fund Experiences Big Outflow
Monday, February 12, 11:41 AM ET, by Market News Video Staff

Symbols mentioned in this story: XLV, JNJ, TMO, CELG Exchange traded funds (ETFs) trade just ...

Noteworthy Wednesday Option Activity: AOBC, CELG, MCD
Wednesday, February 14, 3:19 PM ET, by Market News Video Staff

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume ...

Cardiovascular Systems Becomes Oversold (CSII)
Wednesday, February 14, 4:26 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Bearish Two Hundred Day Moving Average Cross - LMNX

By Market News Video Staff, Friday, August 5, 3:14 PM ET
Play Video: Learn About The 200 DMA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Luminex Corp (NASDAQ:LMNX) crossed below their 200 day moving average of $18.92, changing hands as low as $18.47 per share. Luminex Corp shares are currently trading up about 0.1% on the day. The chart below shows the one year performance of LMNX shares, versus its 200 day moving average:

Luminex Corp 200 Day Moving Average Chart

Looking at the chart above, LMNX's low point in its 52 week range is $14.25 per share, with $21.89 as the 52 week high point that compares with a last trade of $19.76.

According to the ETF Finder at ETF Channel, LMNX makes up 3.25% of the Dynamic Biotechnology & Genome Portfolio ETF (AMEX:PBE) which is trading relatively unchanged on the day Friday.

See what other ETFs contain LMNX
See what other stocks are held by PBE

LMNX operates in the Biotechnology sector, among companies like Celgene Corp. (NASDAQ:CELG) which is up about 0.7% today, and Gilead Sciences, Inc. (NASDAQ:GILD) trading higher by about 1.7%. Below is a three month price history chart comparing the stock performance of LMNX, versus CELG and GILD.

LMNX,CELG,GILD Relative Performance Chart


The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.

This Article's Word Cloud:   AMEX   According   Average   Below   Biotechnology   CELG   Celgene   Channel   Corp   Crossing   Dynamic   ETFs   Finder   Flexible   Free   Friday   GILD   Genome   Gilead   Growth   Investment   LMNX   Looking   Luminex   Moving   Portfolio   Sciences   Start   Stocks   Their   about   asset   average   below   chart   designed   moving   other   performance   point   portfolio   share   shares   stocks   trading   versus   week   what   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Portfolio Channel Stock Market Definitions

Bearish Two Hundred Day Moving Average Cross - LMNX | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.